 |
 |
It's early. I meant Amatryptyline, not Amantadine. ----- Original Message ----- From: Greg Sterling <[log in to unmask]> To: <[log in to unmask]> Sent: Wednesday, October 31, 2001 3:51 AM Subject: Re: Eldepryl (selegiline) pros & cons > Several years ago I was taking Eldepryl and Amantadine and had horrible side > effects. Paranoia, hallucinations, panic attacks, and personality changes. > I was one of the cases that determined the two don't mix. Be very cautious > with this combination. > > > Greg > 49/35/35 > > > > --- Original Message ----- > From: nkporter <[log in to unmask]> > To: <[log in to unmask]> > Sent: Tuesday, October 30, 2001 6:07 PM > Subject: Eldepryl (selegiline) pros & cons > > > > Anybody, feedback please. > > > > Although I have found Amantadine to be very helpful at reducing extreme > > fatigue, I have been having unpleasant side effects (swelling ankles and > > "livido reticularis"). I have (with MD concurrance) been slowly phasing > > it out. It has been suggested I might try taking Eldepryl (selegiline) > > instead. > > > > I have read the PDR literature on this and I think it looks kind of > > extreme and maybe risky. Does anyone on the list have experience with > > Eldepryl, good or bad? > > > > I am also taking an unnamed dopamine agonist, in a long term clinical > > trial. So far, my approximately 18 month experience with this new > > agonist is very positive, with no noticeable side effects. > > > > Nancy K. > > 64 now/ DX 62/ vague since 56 > > > > ---------------------------------------------------------------------- > > To sign-off Parkinsn send a message to: > mailto:[log in to unmask] > > In the body of the message put: signoff parkinsn > > > > ---------------------------------------------------------------------- > To sign-off Parkinsn send a message to: mailto:[log in to unmask] > In the body of the message put: signoff parkinsn > ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn